Clinical trials
Phase 3 Carcinoma, Ductal, Breast trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intarcia Therapeutics | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| GBG Forschungs GmbH | 2 |
| RenJi Hospital | 2 |
| Chinese Academy of Medical Sciences | 1 |
| ETOP IBCSG Partners Foundation | 1 |
| Eastern Cooperative Oncology Group | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Fondazione Michelangelo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ductal, Breast | 16 |
| Breast Neoplasms | 11 |
| Carcinoma, Lobular | 6 |
| Inflammatory Breast Neoplasms | 3 |
| Neoplasms, Hormone-Dependent | 3 |
| Breast Carcinoma In Situ | 2 |
| Hot Flashes | 1 |
| Neoplasm Metastasis | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.